Levofloxacin. Expediency of High-Dose Regimens in Therapy of Lower Respiratory Tract Infections
I. A. Guchev+2 more
doaj
Globotriaosylceramide as a potential biomarker for auxiliary detection of lower respiratory tract infections of <i>Pseudomonas aeruginosa</i>. [PDF]
Xu T, Li J, Dong Y, Zhao Z, Yu L.
europepmc +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant+17 more
wiley +1 more source
Transforming Microbiological Diagnostics in Nosocomial Lower Respiratory Tract Infections: Innovations Shaping the Future. [PDF]
Bustos IG+3 more
europepmc +1 more source
Detecting Respiratory Pathogens for Diagnosing Lower Respiratory Tract Infections at the Point of Care: Challenges and Opportunities. [PDF]
Bouzada FM+4 more
europepmc +1 more source
Molecular genetic methods in the diagnosis of lower respiratory tract infections [PDF]
David R. Murdoch
openalex +1 more source
Immune cell dynamics in heart failure: implicated mechanisms and therapeutic targets
Abstract The relationship between heart failure (HF) and immune activation has garnered significant interest. Studies highlight the critical role of inflammation in HF, affecting cardiac structure and function. Despite promising anti‐inflammatory therapies, clinical trials have faced challenges, indicating an incomplete understanding of immune ...
Gen Li, Wu He, Dao Wen Wang
wiley +1 more source
Rising prevalence and drug resistance of <i>Corynebacterium striatum</i> in lower respiratory tract infections. [PDF]
Li W, Gao M, Yu J.
europepmc +1 more source